Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Unknown 1

Sponsor Class

OTHER 105NETWORK 7INDUSTRY 5OTHER_GOV 3NIH 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 2Genitourinary 1

Conditions

Carcinoma, Hepatocellular 2Prostate Adenocarcinoma 1

Interventions

Cisplatin 48Capecitabine 41Gemcitabine 33apatinib 32Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Nivolumab 17pembrolizumab 16Surgical Procedures, Operative 16Exercise 16Metformin 15S 1 (combination) 14camrelizumab 13Radiation 13Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11Vinorelbine 10Standard of Care 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Proton Therapy × Clear all
NCT02395523 2020-07-07

Hypofractionated Proton Beam Radiotherapy for Inoperable Hepatocellular Carcinoma

National Cancer Center, Korea

Phase NA Completed
45 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01643824 2018-08-23

Hypofractionated Proton Beam Radiotherapy for Hepatocellular Carcinoma

National Cancer Center, Korea

Phase NA Completed
112 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT03285815 2017-09-18

Prostate Cancer - Localized Adenocarcinoma Proton Therapy

National Cancer Center, Korea

Phase NA Unknown
156 enrolled
Genitourinary

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡